Skip to main content

A Phase II Clinical Study of mFOLFOX6 Plus Bevacizumab as First-line Therapy for Japanese Advanced/Recurrent Colorectal Cancer Patients.

Item Preview

SIMILAR ITEMS (based on metadata)